West Tower Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
CAM
West Tower Group's LMAT Position: Q1 2024 in Review
West Tower Group sold out of LeMaitre Vascular (LMAT) in Q1 2024, closing a stake of 467 shares — an estimated $26.5K sold.
West Tower Group first reported a position in LMAT in Q2 2023 and held it in 3 quarters. The position peaked at $26.5K in Q4 2023. 243 funds tracked by Wall St. Rank hold LMAT as of Q1 2024.
- West Tower Group reported no remaining LeMaitre Vascular position as of Q1 2024 after selling out during the quarter.
- West Tower Group sold 467 LeMaitre Vascular shares in Q1 2024, an estimated $26.5K.
- West Tower Group first reported a position in LeMaitre Vascular in Q2 2023 and held it in 3 quarters.
- West Tower Group's LeMaitre Vascular position peaked at $26.5K in Q4 2023.
- 243 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2024.
Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.